Gary Lyons
Chairman presso TRAVERE THERAPEUTICS, INC.
Patrimonio netto: 27 M $ in data 31/03/2024
Profilo
Gary A. Lyons è un uomo d'affari che ha fondato GL Biomed e che è stato a capo di 5 diverse aziende. Il signor Lyons è presidente di Rigel Pharmaceuticals, Inc., presidente di Travere Therapeutics, Inc. e presidente di GL Biomed. Il sig. Lyons è anche nel consiglio di Neurocrine Biosciences, Inc. (ex presidente, amministratore delegato e direttore), Eledon Pharmaceuticals, Inc. e Brickell Biotech, Inc. In precedenza ha occupato la posizione di presidente esecutivo di NeurogesX, Inc., di vicepresidente dello sviluppo del business e delle vendite presso Genentech, Inc. e di direttore delle vendite - American Critical Care presso American Hospital Supply Corp. Il sig. Lyons ha conseguito una laurea presso l'Università del New Hampshire e un MBA presso la Kellogg School of Management.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
22/12/2023 | 193 697 ( 0.19% ) | 27 M $ | 31/03/2024 | |
17/05/2023 | 44 500 ( 0.06% ) | 343 095 $ | 31/03/2024 | |
26/05/2023 | 75 000 ( 0.04% ) | 111 000 $ | 31/03/2024 | |
01/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Gary Lyons
Società | Posizione | Inizio |
---|---|---|
NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 01/02/1993 |
RIGEL PHARMACEUTICALS, INC. | Director/Board Member | 01/10/2005 |
TRAVERE THERAPEUTICS, INC. | Chairman | 18/05/2016 |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Director/Board Member | 01/01/2018 |
GL Biomed | Founder | 01/03/2008 |
Precedenti posizioni note di Gary Lyons
Società | Posizione | Fine |
---|---|---|
FRESH TRACKS THERAPEUTICS, INC. | Director/Board Member | 02/10/2023 |
ELEDON PHARMACEUTICALS, INC. | Director/Board Member | 21/06/2023 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Director/Board Member | 01/08/2019 |
PLUS THERAPEUTICS, INC. | Director/Board Member | 30/01/2019 |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Gary Lyons
University of New Hampshire | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 8 |
---|---|
PONIARD PHARMACEUTICALS, INC. | Health Technology |
NEUROCRINE BIOSCIENCES, INC. | Health Technology |
RIGEL PHARMACEUTICALS, INC. | Health Technology |
HUMANIGEN, INC. | Health Technology |
PLUS THERAPEUTICS, INC. | Health Technology |
TRAVERE THERAPEUTICS, INC. | Health Technology |
ELEDON PHARMACEUTICALS, INC. | Health Technology |
FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
Aziende private | 10 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
American Hospital Supply Corp. | Health Technology |
NeurogesX, Inc.
NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
GL Biomed | |
Kalobios Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Gary Lyons